NCT00481065View on ClinicalTrials.gov

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

405

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

PandemicAvian Influenza

Interventions

BIOLOGICAL

MF59-eH5N1

BIOLOGICAL

eTIV_a

BIOLOGICAL

MF59-eH5N1 + eTIV_a

Trial Locations (1)

Unknown

Bogotá

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY